Skip to main content
OpenTrials

Clinical trial condition

Myasthenia Gravis

Explore clinical trials studying Myasthenia Gravis. Study availability and eligibility vary by location and protocol.

259 public trials 95 recruiting studies
Refine in advanced search Browse all conditions

Myasthenia Gravis trial results

Active, Not Recruiting

A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)

NCT06282159

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • Clinical Study Site Phoenix, Arizona, United States
  • Clinical Study Site Irvine, California, United States
  • Clinical Study Site Stamford, Connecticut, United States
  • Clinical Study Site Boca Raton, Florida, United States
View all 56 locations
View Trial Details
Active, Not Recruiting

Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis

NCT04225871

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Mg0011 41 Mobile, Alabama, United States
  • Mg0011 116 Phoenix, Arizona, United States
  • Mg0011 31 Irvine, California, United States
  • MG0011 4 Los Angeles, California, United States
View all 70 locations
View Trial Details
Active, Not Recruiting

A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis

NCT05070858

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • HonorHealth Neurology 2018 Scottsdale, Arizona, United States
  • University of California Irvine Irvine, California, United States
  • University of Southern California Los Angeles, California, United States
  • Colorado Springs Neurological Associates Colorado Springs, Colorado, United States
View all 116 locations
View Trial Details
Active, Not Recruiting

A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis

NCT06558279

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • HonorHealth Neurology - Bob Bové Neuroscience Institute Scottsdale, Arizona, United States
  • Loma Linda University Health Loma Linda, California, United States
  • USC Roski Eye Institute - Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
View all 102 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis

NCT05556096

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Research Site Orange, California, United States
  • Research Site Fort Collins, Colorado, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Bradenton, Florida, United States
View all 132 locations
View Trial Details
Active, Not Recruiting

Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis

NCT06106672

Conditions
AChR Myasthenia Gravis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +13 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Infusion for Health Brea, California, United States
  • University of California, Irvine Orange, California, United States
  • University of California, Davis Sacramento, California, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis

NCT05403541

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Site Number -1022 Phoenix, Arizona, United States
  • Site Number -1029 Scottsdale, Arizona, United States
  • Site Number -1002 Carlsbad, California, United States
  • Site Number -1009 Irvine, California, United States
View all 93 locations
View Trial Details

Related conditions